Search Results 831-840 of 16987 for pharmacogenetics
The purpose of this study is to determine the maximum tolerated dose of the combination of ABT-888 and weekly topotecan in adult patients with advanced solid ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic Researchers Identify Potential Immunotherapy Drug Combination for Targeting Advanced and Metastatic Cancers. Julie Janovsky-Mason. July 12, 2016.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...
About this study. This is an open-label, multicenter, phase 2 clinical trial to evaluate the antitumor activity of brentuximab vedotin as a single agent in ...
About this study. The purpose of this study is to obtain time-series pressure (mmHg) data using a non-invasive pneumatic capture device designed by the Mayo ...
Latest stories · Discovery's Edge: A Foundation of Cancer Research featured image · Sharing Mayo Clinic: Genetic Testing Uncovers the Reason for Years of ...
On Saturday, Oct. 5, we will broadcast from the Individualizing Medicine Conference, in Rochester, Minn. We'll discuss how the promise of genomic medicine has ...
Pharmacogenetic Testing in Children With Persistent Gastroesophageal Reflux Disease Rochester, MN. This study will use a 22 gene pharmacogenomics panel on 30 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.